# OraSure Technologies, Inc. (OSUR)

> Source: Nexqual · https://nexqual.com/OSUR · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, OraSure Technologies, Inc. (OSUR), nexqual.com/OSUR" · informational, not investment advice.

**Price:** USD 3.81 (+2.70% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 3.71 · day 3.71–3.83 · 52w 2.08–4.58 · market cap $263M · NMS

## Key facts
- 1 of 80 tracked superinvestors hold OSUR (13F, Q2 2026): 1 new, 0 added, 0 reduced, 0 unchanged.
- Analysts: Hold (mean 3.00 on a 1–5 scale) (1 analysts), mean target USD 4 (range 4–4).
- Total return with dividends: 1Y +24.5% vs S&P 500 +18.1%; 5Y -63.8% vs S&P 500 +85.1%.
- Next earnings: 2026-11-04, EPS estimate USD -0.18, revenue estimate $31.1M.

## Superinvestors (SEC 13F-HR, Q2 2026)
1 of 80 tracked investors hold OSUR. Change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.01% | $4.7M | New position |

## Analysts
Consensus Hold (mean 3.00 on a 1–5 scale), 1 analysts; mean target USD 4 (low 4, high 4).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | +24.5% | -63.8% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +24.6% | -18.3% |
| Volatility (annualized) | 47.5% | 51.0% |
| Max drawdown | -31.1% (Oct 2025→Nov 2025) | -79.1% (Oct 2021→Nov 2025) |

## Peers (Medical Instruments & Supplies)
KMTS (Kestra Medical Technologies, Lt) USD 28.68 +6.34% · XRAY (DENTSPLY SIRONA Inc.) USD 8.83 +3.76% · LMAT (LeMaitre Vascular, Inc.) USD 83.16 +1.97% · ATRC (AtriCure, Inc.) USD 57.78 +1.60% · WRBY (Warby Parker Inc.) USD 24.59 -7.28% · PLSE (Pulse Biosciences, Inc) USD 45.59 -6.08%

## More
Full page: https://nexqual.com/OSUR · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt